Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 6 » default
Diabetes, Metabolic Syndrome and Obesity
ISSN: 1178-7007
- View all (2147)
- Volume 16, 2023 (75)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Archive: Volume 6, 2013
Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin
Jurczyk A, diIorio P, Brostowin D, Leehy L, Yang C, Urano F, Harlan DM, Shultz LD, Greiner DL, Bortell R
Diabetes, Metabolic Syndrome and Obesity 2013, 6:493-499
Published Date: 13 December 2013
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
Kowall B, Rathmann W
Diabetes, Metabolic Syndrome and Obesity 2013, 6:477-491
Published Date: 29 November 2013
The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects
Lopes AL, Fayh AP, Campos LG, Teixeira BC, Carteri RBK, Ribeiro JL, Friedman R, Reischak-Oliveira A
Diabetes, Metabolic Syndrome and Obesity 2013, 6:469-475
Published Date: 29 November 2013
SGLT-2 inhibitors and their potential in the treatment of diabetes
Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ
Diabetes, Metabolic Syndrome and Obesity 2013, 6:453-467
Published Date: 27 November 2013
Effects of a recreational physical activity and healthy habits orientation program, using an illustrated diary, on the cardiovascular risk profile of overweight and obese schoolchildren: a pilot study in a public school in Brasilia, Federal District, Brazil
Militão AG, Karnikowski MGO, Silva FR, Militão ESG, Pereira RMS, Campbell CSG
Diabetes, Metabolic Syndrome and Obesity 2013, 6:445-451
Published Date: 27 November 2013
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
Stolar MW, Grimm M, Chen S
Diabetes, Metabolic Syndrome and Obesity 2013, 6:435-444
Published Date: 22 November 2013
Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans
Nakanishi S, Yoneda M, Maeda S
Diabetes, Metabolic Syndrome and Obesity 2013, 6:427-433
Published Date: 22 November 2013
Importance of family/social support and impact on adherence to diabetic therapy
Miller TA, DiMatteo MR
Diabetes, Metabolic Syndrome and Obesity 2013, 6:421-426
Published Date: 6 November 2013
Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis
Savva SC, Lamnisos D, Kafatos AG
Diabetes, Metabolic Syndrome and Obesity 2013, 6:403-419
Published Date: 24 October 2013
The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review
Rolland C, Mavroeidi A, Johnston KL, Broom J
Diabetes, Metabolic Syndrome and Obesity 2013, 6:393-401
Published Date: 11 October 2013
Evaluation of the maximum beyond-use-date stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag
Rocchio MA, Belisle CD, Greenwood BC, Cotugno MC, Szumita PM
Diabetes, Metabolic Syndrome and Obesity 2013, 6:389-392
Published Date: 11 October 2013
Hepatic function and the cardiometabolic syndrome
Wiernsperger N
Diabetes, Metabolic Syndrome and Obesity 2013, 6:379-388
Published Date: 10 October 2013
Socioeconomic status and obesity in Abia State, South East Nigeria
Chukwuonye II, Chuku A, Okpechi IG, Onyeonoro UU, Madukwe OO, Okafor GOC, Ogah OS
Diabetes, Metabolic Syndrome and Obesity 2013, 6:371-378
Published Date: 16 October 2013
Radiographic evaluation of the effect of obesity on alveolar bone in rats with ligature-induced periodontal disease
do Nascimento CM, Cassol T, da Silva FS, Bonfleur ML, Nassar CA, Nassar PO
Diabetes, Metabolic Syndrome and Obesity 2013, 6:365-370
Published Date: 7 October 2013
Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
Scott D
Diabetes, Metabolic Syndrome and Obesity 2013, 6:359-363
Published Date: 2 October 2013
Systematic review of clinical studies related to pork intake and metabolic syndrome or its components
Stettler N, Murphy MM, Barraj LM, Smith KM, Ahima RS
Diabetes, Metabolic Syndrome and Obesity 2013, 6:347-357
Published Date: 25 September 2013
Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study
Bonet J, Martinez-Castelao A, Bayés B
Diabetes, Metabolic Syndrome and Obesity 2013, 6:339-346
Published Date: 18 September 2013
Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
Colosia AD, Palencia R, Khan S
Diabetes, Metabolic Syndrome and Obesity 2013, 6:327-338
Published Date: 17 September 2013
Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
Konya H, Katsuno T, Tsunoda T, Yano Y, Kamitani M, Miuchi M, Hamaguchi T, Miyagawa JI, Namba M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:317-325
Published Date: 2 September 2013
Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects
Zemel MB, Bruckbauer A
Diabetes, Metabolic Syndrome and Obesity 2013, 6:309-315
Published Date: 23 August 2013
Treatment outcome and prognostic indices in patients with hyperglycemic emergencies
Ezeani IU, Eregie A, Ogedengbe OS
Diabetes, Metabolic Syndrome and Obesity 2013, 6:303-307
Published Date: 19 August 2013
Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O
Diabetes, Metabolic Syndrome and Obesity 2013, 6:293-301
Published Date: 13 August 2013
Prevalence of abdominal obesity in Abia State, Nigeria: results of a population-based house-to-house survey
Chukwuonye II, Chuku A, Onyeonoro UU, Okpechi IG, Madukwe OO, Umeizudike TI, Ogah OS
Diabetes, Metabolic Syndrome and Obesity 2013, 6:285-291
Published Date: 1 August 2013
Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
Usharani P, Fatima N, Muralidhar N
Diabetes, Metabolic Syndrome and Obesity 2013, 6:275-284
Published Date: 26 July 2013
Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
Cuevas-Ramos D, Almeda-Valdés P, Chávez-Manzanera E, Meza-Arana CE, Brito-Córdova G, Mehta R, Pérez-Méndez O, Gómez-Pérez FJ
Diabetes, Metabolic Syndrome and Obesity 2013, 6:263-273
Published Date: 26 July 2013
Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
Noto H, Goto A, Tsujimoto T, Noda M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:257-261
Published Date: 26 July 2013
Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials
Yang F, Ye J, Pomerantz K, Stewart M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:247-256
Published Date: 12 July 2013
Association of FTO and PPARG polymorphisms with obesity in Portuguese women
Ferreira Carlos F, Silva-Nunes J, Flores O, Brito M, Doria G, Veiga L, Baptista PV
Diabetes, Metabolic Syndrome and Obesity 2013, 6:241-245
Published Date: 11 July 2013
Evidence for the benefit of exercise therapy in patients with type 2 diabetes
Madden KM
Diabetes, Metabolic Syndrome and Obesity 2013, 6:233-239
Published Date: 3 July 2013
Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
Petersen AB, Christensen M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:217-231
Published Date: 17 June 2013
Lorcaserin for weight management
Taylor JR, Dietrich E, Powell J
Diabetes, Metabolic Syndrome and Obesity 2013, 6:209-216
Published Date: 13 June 2013
Management of limited joint mobility in diabetic patients
Abate M, Schiavone C, Salini V, Andia I
Diabetes, Metabolic Syndrome and Obesity 2013, 6:197-207
Published Date: 7 May 2013
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
Kishimoto M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:187-195
Published Date: 6 May 2013
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
Ostenson CG, Matthaei S, Reaney M, Krarup T, Guerci B, Kiljanski J, Salaun-Martin C, Sapin H, Bruhn D, Mathieu C, Theodorakis M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:171-185
Published Date: 26 April 2013
Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin
Russo E, Penno G, Del Prato S
Diabetes, Metabolic Syndrome and Obesity 2013, 6:161-170
Published Date: 24 April 2013
Predictors and prevention of diabetic cardiomyopathy
Chavali V, Tyagi SC, Mishra PK
Diabetes, Metabolic Syndrome and Obesity 2013, 6:151-160
Published Date: 11 April 2013
An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco
Shihabi AR, Moussa EM, Sobierajska H, Schmidt B
Diabetes, Metabolic Syndrome and Obesity 2013, 6:141-150
Published Date: 9 April 2013
Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
Shin JH, Gadde KM
Diabetes, Metabolic Syndrome and Obesity 2013, 6:131-139
Published Date: 8 April 2013
Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience
Anichini R, Cosimi S, Di Carlo A, Orsini P, De Bellis A, Seghieri G, Franconi F, Baccetti F
Diabetes, Metabolic Syndrome and Obesity 2013, 6:123-129
Published Date: 8 April 2013
The impact of brief high-intensity exercise on blood glucose levels
Adams OP
Diabetes, Metabolic Syndrome and Obesity 2013, 6:113-122
Published Date: 27 February 2013
Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Kashtalap V, Barbarash O
Diabetes, Metabolic Syndrome and Obesity 2013, 6:103-111
Published Date: 18 February 2013
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
Bruckbauer A, Zemel MB
Diabetes, Metabolic Syndrome and Obesity 2013, 6:93-102
Published Date: 13 February 2013
Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
Sadosky A, Schaefer C, Mann R, Bergstrom F, Baik R, Parsons B, Nalamachu S, Nieshoff E, Stacey BR, Anschel A, Tuchman M
Diabetes, Metabolic Syndrome and Obesity 2013, 6:79-92
Published Date: 8 February 2013
Guidelines in the management of diabetic nerve pain clinical utility of pregabalin
Vinik AI, Casellini CM
Diabetes, Metabolic Syndrome and Obesity 2013, 6:57-78
Published Date: 22 February 2013
Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N, Bhandari V, Khurana A
Diabetes, Metabolic Syndrome and Obesity 2013, 6:49-56
Published Date: 19 January 2013
Prevalence of overweight and obesity in adult Nigerians – a systematic review
Chukwuonye II, Chuku A, John C, Ohagwu KA, Imoh ME, Isa SE, Ogah OS, Oviasu E
Diabetes, Metabolic Syndrome and Obesity 2013, 6:43-47
Published Date: 22 January 2013
Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
MacConell L, Pencek R, Li Y, Maggs D, Porter L
Diabetes, Metabolic Syndrome and Obesity 2013, 6:31-41
Published Date: 21 January 2013
Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review
Holmes C, Wrobel JS, MacEachern MP, Boles BR
Diabetes, Metabolic Syndrome and Obesity 2013, 6:17-29
Published Date: 17 January 2013
Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
Feher M, Greener M, Munro N
Diabetes, Metabolic Syndrome and Obesity 2013, 6:11-15
Published Date: 10 January 2013
Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
Gallwitz B
Diabetes, Metabolic Syndrome and Obesity 2013, 6:1-9
Published Date: 4 January 2013